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Background
Novel and innovative health informatics strategies have
shown to help in HIV-behavior research. As a first step to
build novel informatics tools for clinical trials research at
developing countries, we developed a computer assisted
self interviewing (CASI) application, that was validated by
the U.S. NIH and manages with straightforward efficiency
sexual behavior data from men who have sex with men
(MSM) participating in HIV prevention studies.
Methods
During 2004, Biostatistics Data Management and Infor-
matics Unit from Peruvian Clinical Trials Unit (CTU)
developed a fully featured web CASI named SISQUAL,
that permits to create and deploy questionnaires ranging
from standard scroll-down forms to those with complex
skipping, advanced list handling, multi-lingual interview-
ing, piping, and online and offline data viewing. It was
built following data management principles and CRF21
part 11 security features.
Results
More than 7,700 MSM has completed semi-structured
interviews that included topics on their sexual identifica-
tion, sexual behavior, and their experiences with condom,
alcohol and drugs having sex with their partners. CASI,
translated in 8 languages (Spanish, English, Portuguese,
Thai, Sesotho, Afrikaans, Xhosa, and Zulu), provides web
data collection, auditing, and integration by providing
automatic quality control checking, branching and skip-
ping questions collecting data for the Peruvian HIV and
STD third generation sentinel surveillance in 2006 and
2008 (Arequipa, Ica, Iquitos, Lima, Sullana, and Pucallpa)
and international sites (Cape Town, Chennai, Guayaquil,
Johannesburg, New York, Rio Janeiro, San Francisco, Sao
Paulo, and Seattle) for U.S. NIH funded trials.
Conclusion
An innovative fully featured web based CASI developed
for the Peruvian CTU collects sexual behavior data with
straightforward efficiency as a first step to increase clinical
trial site capacity for challenging AIDS vaccine research
agenda.
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